Will integrin inhibitors have proangiogenic effects in the clinic?
Weller
Michael
M
Reardon
David
D
Nabors
Burt
B
Stupp
Roger
R
D000818:Animals; D005909:Glioblastoma / Q000188:drug therapy; D006801:Humans; D016023:Integrins / Q000037:antagonists & inhibitors*; D009389:Neovascularization, Pathologic / Q000139:chemically induced*; D012910:Snake Venoms / Q000009:adverse effects*
D016023:Integrins; D012910:Snake Venoms; C422910:Cilengitide